Giordano Nicoletti

6.0k total citations
140 papers, 4.9k citations indexed

About

Giordano Nicoletti is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Giordano Nicoletti has authored 140 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Immunology, 54 papers in Oncology and 50 papers in Molecular Biology. Recurrent topics in Giordano Nicoletti's work include Immunotherapy and Immune Responses (48 papers), Sarcoma Diagnosis and Treatment (35 papers) and Immune Cell Function and Interaction (23 papers). Giordano Nicoletti is often cited by papers focused on Immunotherapy and Immune Responses (48 papers), Sarcoma Diagnosis and Treatment (35 papers) and Immune Cell Function and Interaction (23 papers). Giordano Nicoletti collaborates with scholars based in Italy, United States and Switzerland. Giordano Nicoletti's co-authors include Pier‐Luigi Lollini, Patrizia Nanni, Carla De Giovanni, Lorena Landuzzi, Katia Scotlandi, Maria Cristina Manara, Piero Picci, Annalisa Astolfi, Stefania Croci and Giorgio Prodi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Giordano Nicoletti

139 papers receiving 4.8k citations

Peers

Countries citing papers authored by Giordano Nicoletti

Since Specialization

Citations

This map shows the geographic impact of Giordano Nicoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giordano Nicoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giordano Nicoletti more than expected).

Fields of papers citing papers by Giordano Nicoletti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giordano Nicoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giordano Nicoletti. The network helps show where Giordano Nicoletti may publish in the future.

Co-authorship network of co-authors of Giordano Nicoletti

This figure shows the co-authorship network connecting the top 25 collaborators of Giordano Nicoletti. A scholar is included among the top collaborators of Giordano Nicoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giordano Nicoletti. Giordano Nicoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy 2018 ·Molecular Cancer Therapeutics ·Maria Cristina Manara, Sérgio Valente, (unknown), Giordano Nicoletti, Lorena Landuzzi, Clemens Zwergel, Roberta Mazzone, Giulia Stazi, Paola B. Arimondo, Michela Pasello, Clara Guerzoni, Piero Picci, Patrizia Nanni, Pier‐Luigi Lollini, Antonello Mai, Katia Scotlandi	38
2	Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases 2015 ·Oncotarget ·Valerio Leoni, Valentina Gatta, Arianna Palladini, Giordano Nicoletti, (unknown), Massimiliano Dall’Ora, Valentina Grosso, Martina Rossi, Francesco Alviano, Laura Bonsi, Patrizia Nanni, Pier‐Luigi Lollini, Gabriella Campadelli‐Fiume	64
3	CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin 2014 ·Clinical Cancer Research ·Clara Guerzoni, (unknown), (unknown), Maria Cristina Manara, (unknown), Michela Pasello, Marika Sciandra, Giordano Nicoletti, (unknown), Sabrina Dominici, Claudia Chiodoni, Pier Maria Fornasari, Pier‐Luigi Lollini, Mario P. Colombo, Piero Picci, Maurizio Cianfriglia, Mauro Magnani, Katia Scotlandi	40
4	Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus 2013 ·PLoS Pathogens ·Patrizia Nanni, Valentina Gatta, Laura Menotti, Carla De Giovanni, Marianna L. Ianzano, Arianna Palladini, Valentina Grosso, Massimiliano Dall’Ora, Stefania Croci, Giordano Nicoletti, Lorena Landuzzi, Manuela Iezzi, Gabriella Campadelli‐Fiume, Pier‐Luigi Lollini	43
5	A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1 , an Oncojanus Function 2011 ·Cancer Research ·Giuseppe Gasparre, Ivana Kurelac, Mariantonietta Capristo, Luisa Iommarini, Anna Ghelli, Claudio Ceccarelli, Giordano Nicoletti, Patrizia Nanni, Carla De Giovanni, Katia Scotlandi, Christine M. Betts, Valério Carelli, Pier‐Luigi Lollini, G. Cara Romeo, Michela Rugolo, Anna Maria Porcelli	81
6	HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines 2011 ·Vaccine ·Lorena Landuzzi, Agnese Antognoli, Giordano Nicoletti, Stefania Croci, Arianna Palladini, Marianna L. Ianzano, (unknown), (unknown), Valentina Grosso, Patrizia Nanni, Carla De Giovanni, Pier‐Luigi Lollini	4
7	NVP-BEZ235 as a New Therapeutic Option for Sarcomas 2010 ·Clinical Cancer Research ·Maria Cristina Manara, Giordano Nicoletti, Diana Zambelli, Selena Ventura, Clara Guerzoni, Lorena Landuzzi, Pier‐Luigi Lollini, (unknown), Carlos Garcı́a-Echeverrı́a, Mario Mercuri, Piero Picci, Katia Scotlandi	128
8	In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations 2010 ·Cancer Research ·Arianna Palladini, Giordano Nicoletti, Francesco Pappalardo, (unknown), Valentina Grosso, (unknown), Marianna L. Ianzano, Agnese Antognoli, Stefania Croci, Lorena Landuzzi, Carla De Giovanni, Patrizia Nanni, Santo Motta, Pier‐Luigi Lollini	69
9	Immunoprevention and Immunotherapy of Mammary Carcinoma 2010 ·The Breast Journal ·Pier‐Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, Carla De Giovanni, Patrizia Nanni	5
10	Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells 2009 ·Proceedings of the National Academy of Sciences ·Laura Menotti, Giordano Nicoletti, Valentina Gatta, Stefania Croci, Lorena Landuzzi, Carla De Giovanni, Patrizia Nanni, Pier‐Luigi Lollini, Gabriella Campadelli‐Fiume	77
11	Insulin‐like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma 2006 ·International Journal of Cancer ·Stefania Benini, Monia Zuntini, Maria Cristina Manara, Pinchas Cohen, Giordano Nicoletti, Patrizia Nanni, Youngman Oh, Piero Picci, Katia Scotlandi	45
12	New Target Antigens for Cancer Immunoprevention 2005 ·Current Cancer Drug Targets ·Pier‐Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, Carla De Giovanni, Patrizia Nanni	8
13	Immunoprevention of HER-2/ *neu* Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine 2004 ·Cancer Research ·Carla De Giovanni, Giordano Nicoletti, Lorena Landuzzi, Annalisa Astolfi, Stefania Croci, Alberto Comes, Silvano Ferrini, Raffaella Meazza, Manuela Iezzi, Emma Di Carlo, Piero Musiani, Federica Cavallo, Patrizia Nanni, Pier‐Luigi Lollini	64
14	Immunoprevention of Mammary Carcinoma in HER-2/ neu Transgenic Mice Is IFN-γ and B Cell Dependent 2004 ·The Journal of Immunology ·Patrizia Nanni, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Ilaria Rossi, Stefania Croci, Annalisa Astolfi, Manuela Iezzi, Emma Di Carlo, Piero Musiani, Guido Forni, Pier‐Luigi Lollini	78
15	HER/erbB Receptors as Therapeutic Targets of Immunotoxins in Human Rhabdomyosarcoma Cells 2002 ·Journal of Immunotherapy ·Cinzia Ricci, Letizia Polito, Patrizia Nanni, Lorena Landuzzi, Annalisa Astolfi, Giordano Nicoletti, Ilaria Rossi, Carla De Giovanni, Andrea Bolognesi, Pier‐Luigi Lollini	30
16	Immunological prevention of spontaneous tumors: a new prospect? 2002 ·Immunology Letters ·Elena Quaglino, (unknown), Federica Cavallo, Piero Musiani, Augusto Amici, Giordano Nicoletti, Patrizia Nanni, Guido Forni	16
17	Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice 2001 ·The Journal of Experimental Medicine ·Patrizia Nanni, Giordano Nicoletti, Carla De Giovanni, Lorena Landuzzi, Emma Di Carlo, Federica Cavallo, Serenella M. Pupa, Ilaria Rossi, Mario P. Colombo, Cinzia Ricci, Annalisa Astolfi, Piero Musiani, Guido Forni, Pier‐Luigi Lollini	191
18	Control of H-2 expression in transformed nonhaemopoietic cells by autocrine interferon 1992 ·British Journal of Cancer ·Patrizia Nanni, Lorena Landuzzi, Giordano Nicoletti, Carla De Giovanni, Mirella Giovarelli, Enzo Lalli, Angelo Facchini, Pier‐Luigi Lollini	2
19	Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma 1990 ·Clinical & Experimental Metastasis ·Pier‐Luigi Lollini, Carla De Giovanni, Giordano Nicoletti, Andrea Bontadini, Pier Luigi Tazzari, Lorena Landuzzi, Katia Scotlandi, Patrizia Nanni	37
20	[Measurement of cytoplasmic receptors specific for steroid hormones. IV) Glucocorticoid receptor]. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), Patrizia Nanni, Carla De Giovanni, Giordano Nicoletti, Marco Gobbi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact